MedPath

Pain Control in Dentin Hypersensitivity in Patients With MIH

Phase 1
Conditions
Hypersensitivity Dentin
Registration Number
NCT04268238
Lead Sponsor
University of Nove de Julho
Brief Summary

This study aims to evaluate the effectiveness of different protocols in controlling dentin hypersensitivity in patients with teeth affected by MIH. The subjects will be randomly designated in four experimental groups, according to different treatments. Pain will be assessed with the visual analog scale (Visual Analogue Scale - VAS), after stimulation with air from the triple syringe and and an exploratory probe at the time of (initial) recruitment, immediately after treatment, after 1 week and 1 month, 3 and 6 months after treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Be between 18 and 35 years old;
  • Present good general health;
  • Present at least one tooth with dentin hypersensitivity reported in the cervical region, which must have a graduated sensitivity equal to or greater than 4 in the VAS scale.
Exclusion Criteria
  • Present active caries lesions or restoration defects in the tooth to be analyzed;
  • Present sufficient dentin loss that requires restorative treatment or periodontal surgery;
  • Volunteers who underwent any professional desensitizer treatment in the last 6 months;
  • Volunteers who used desensitizing pastes in the 3 months;
  • Volunteers who were using anti-inflammatory or analgesic drugs at the time of recruitment;
  • Volunteers who are pregnant or breastfeeding.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Pain Evaluated by a Visual Analog Scale (VAS)Baseline, immediately after treatment, 1 week, 1, 3 and 6 months after treatment.

Pain will be assessed with the visual analogue scale (Visual Analogue Scale - VAS), after stimulation with air from the triple syringe and an explorer probe.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.